HD-OPM Archive
Topics › LDL, ApoB & lipid panel

Mendelian randomization shows genetically lower LDL does not raise cancer risk

Louis Nervegna · May 25, 2026 · ♥ 3 reactions · 0 comments · original Facebook post
LDL, ApoB & lipid panelCancerHow to read research
AI summary & key facts

Louis explains that old observational links between low LDL and cancer are largely reverse causality. MR studies find genetically lowered LDL does not increase overall cancer risk, and genetically higher LDL is linked to more breast and prostate cancer; statin proxies lower colorectal cancer risk.

Low LDL and Cancer
Observational studies historically linked low LDL cholesterol to an increased cancer risk. However, modern Mendelian Randomization (MR) studies—which use genetic variants as lifelong proxies—have largely debunked this. They confirm that genetically lowered LDL does not increase cancer risk, and in some contexts, it can even be protective.

Paper · Discov Oncol · 2024Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancers.Conclusion: Analyses using both the HMGCR and PCSK9 genes have shown that LDL-C may be a potential risk factor for breast and prostate cancer, while analyses of the HMGCR gene have also suggested that LDL-C may increase the risk of thyroid cancer and decrease the risk of colorectal cancer.pmc.ncbi.nlm.nih.gov Paper · J Natl Cancer Inst · 2011Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.Conclusion: Low plasma LDL cholesterol levels were robustly associated with an increased risk of cancer, but genetically decreased LDL cholesterol was not. This finding suggests that low LDL cholesterol levels per se do not cause cancer.pubmed.ncbi.nlm.nih.gov

The relationship between LDL-C and cancer, as evaluated by MR methodologies, reveals several specific nuances:

Paper · Elife · 2020Predicting the effect of statins on cancer risk using genetic variants from a Mendelian randomization study in the UK Biobank.Laboratory studies have suggested oncogenic roles of lipids, as well as anticarcinogenic effects of statins. Here we assess the potential effect of statin therapy on cancer risk using evidence from human genetics. We obtained associations of lipid-related genetic variants with the risk of overall and 22 site-specific cancers for 367,703 individuals in the UK Biobank. In total, 75,037 individuals had a cancer event.…pmc.ncbi.nlm.nih.gov eLifeStatins may reduce cancer risk through mechanisms separate to cholesterolNew findings suggest the potential use of statins for cancer prevention should be “urgently evaluated”.elifesciences.org Paper · Food Sci Nutr · 2025Mendelian Randomization Assessment of the Genetic Effects of Lipid-Lowering Drugs on Digestive System Cancers.The relationship between lipid-lowering drugs and the risk of digestive system cancers remains unclear. This study aims to assess the risk association between lipid-lowering drugs and digestive system cancers through mendelian randomization (MR) analysis. We utilized genetic instruments to substitute for the exposure to lipid-lowering drugs, including expression quantitative trait loci (eQTL) for HMGCR, PCSK9, and…pmc.ncbi.nlm.nih.gov Paper · Cancer Prev Res (Phila) · 2010Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR), the rate-limiting enzyme in cholesterol synthesis, modifies the effect of statins on serum cholesterol levels. Long-term use of statins is associated with a reduced risk of colorectal cancer (CRC) in some, but not all, studies. We genotyped variants in 40 candidate genes important for cholesterol synthesis and metabolism in a population-based…pubmed.ncbi.nlm.nih.gov cdas.cancer.govMendelian randomization analyses suggest a role for cholesterol in the … - Publications - The Cancer Data Access SystemCDAS allows the research community to submit research projects to request data, biospecimens, or images from cancer trials and other studies. Approved projects and publications may be viewed.cdas.cancer.gov

Why the Disconnect?

The reason genetically decreased LDL does not cause cancer is that the low LDL levels seen in observational studies are often the consequence of undiagnosed, preclinical cancer, rather than the cause of it (reverse causality). When MR studies remove this reverse causality, researchers find that lifelong low LDL-C is perfectly safe regarding cancer.

GlobalRPHLDL Targets Below 40 mg/dL: How Low Is Too Low in 2026?LDL Targets Below 40 mg/dL: How Low Is Too Low in 2026? Abstract PurposeThis paper evaluates the current evidence supporting the use of very lowlow density lipoprotein (LDL) cholesterol targetsbelow 40 mg per deciliter in contemporary cardiovascular practice and examines whether the benefits of aggressive lipid lowering outweigh potential risks as of 2026.…globalrph.com Paper · J Lipids · 2021Lipoproteins as Markers for Monitoring Cancer Progression.Lipoproteins are among the contributors of energy for the survival of cancer cells. Studies indicate there are complex functions and metabolism of lipoproteins in cancer. The current review is aimed at providing updates from studies related to the monitoring of lipoproteins in different types of cancer. This had led to numerous clinical and experimental studies. The review covers the major lipoproteins such as LDL…pmc.ncbi.nlm.nih.gov Paper · Cancer Epidemiol Biomarkers Prev · 2018Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?Observational epidemiologic studies are prone to confounding, measurement error, and reverse causation, undermining robust causal inference. Mendelian randomization (MR) uses genetic variants to proxy modifiable exposures to generate more reliable estimates of the causal effects of these exposures on diseases and their outcomes. MR has seen widespread adoption within cardio-metabolic epidemiology, but also holds…pmc.ncbi.nlm.nih.gov

#ldlHD #cancerHD #ldlcancerHD #statinscancerHD #ushapedcurveHD #lowldlHD #reversecausalityHD

Research cited

← newer: Statins raise type 2 diabetes risk 9-12% relative, a tiny abolder: Low LDL in cancer patients reflects reverse causality: tumou →